Icu Medical INC/DE earnings releases ICUI

Icu Medical INC/DE last reported quarterly results on Nov 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $560.4 million (+4.4% year over year) and diluted EPS of $1.07. It usually reports 36–50 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 18, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–50 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Nov 5, 2026
36 days after quarter end
Q3 FY2026
ended Sep 30, 2026
560
+4.4%
27
+890.5%
1.07
+864.3%
Aug 6, 2026
37 days after quarter end
Q2 FY2026
ended Jun 30, 2026
552
+0.5%
19
-46.0%
0.76
-46.9%
May 7, 2026
37 days after quarter end
Q1 FY2026
ended Mar 31, 2026
530
-12.3%
30
+294.7%
1.20
+290.5%
Feb 19, 2026
50 days after quarter end
Q4 FY2025
ended Dec 31, 2025
541
-14.1%
—
—
Nov 6, 2025
37 days after quarter end
Q3 FY2025
ended Sep 30, 2025
537
-8.9%
-3
+89.7%
-0.14
+89.6%
Aug 7, 2025
38 days after quarter end
Q2 FY2025
ended Jun 30, 2025
549
-8.0%
35
+265.1%
1.43
+262.5%
May 8, 2025
38 days after quarter end
Q1 FY2025
ended Mar 31, 2025
605
+6.7%
-15
-313.8%
-0.63
+61.3%
Feb 27, 2025
58 days after quarter end
Q4 FY2024
ended Dec 31, 2024
630
+7.1%
—
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ICUI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Clemente, CA
SEC filer status
Large accelerated filer
SEC CIK
883984

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.